Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700451 · ClinicalTrials.gov registry record · NA
Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 178
- Enrollment target
NCT02700451 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 178 participants.
The verdict
NCT02700451, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 178 participants
- Enrollment target
Study Summary
Patients undergoing spine surgery often have considerable pain post-operatively and frequently require opioid medication (Percocet, Norco, oxycodone, morphine, etc.) to control their pain postoperatively. The widespread use of opioids, however, is associated with a number of side effects. These include: sedation, dizziness, nausea, vomiting, constipation, dizziness and itching amongst others. Some investigators have suggested that anti-inflammatory medications (the same class of medicines as advil, ibuprofen, etc.) and acetaminophen (Tylenol) can reduce the total dose of opioid required postoperatively and, as a result, lower opioid-related side effects. The purpose of this study is to test this hypothesis and determine if postoperative anti-inflammatory medications and postoperative acetaminophen can reduce the amount of opioid required to control pain following surgery. A secondary goal of this study is to examine if the change in pain medication will lead to decreased overall pain levels, decreased opioid-related side effects and improved function \[quicker ambulation with physical therapy (PT), earlier return to work, etc.\].
Interventions
- DRUG Placebo
- DRUG Acetaminophen
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 178 participants |
| Start Date | 2016-03 |
| Est. Completion | 2023-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02700451
The ClinicalTrials.gov registry entry for NCT02700451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 178 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02700451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02700451 about?
NCT02700451 is a clinical study titled "Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes". Patients undergoing spine surgery often have considerable pain post-operatively and frequently require opioid medication (Percocet, Norco, oxycodone, morphine, etc.) to control their pain postoperatively. The widespread use of opioids, however, is associated with a number of side effects. These incl...
What is the current status of trial NCT02700451?
This trial is currently completed. It is a NA study. The enrollment target is 178 participants. The study started on 2016-03. Estimated completion is 2023-03.
What interventions are being tested in trial NCT02700451?
The interventions under investigation include: Placebo (DRUG), Acetaminophen (DRUG), Ketorolac (DRUG).
Who is sponsoring clinical trial NCT02700451?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.